BPC-157
A gastric-derived research peptide studied primarily in preclinical tissue-repair and gastrointestinal models.
Search peptides, goals, protocols and references
WOMEN-CENTERED PERFORMANCE RESEARCH
Peptides, protocols, calculators and reference tools for women navigating emerging performance science.
FEATURED PEPTIDE
A gastric-derived research peptide studied primarily in preclinical tissue-repair and gastrointestinal models.
A vendor-defined blend name commonly combining repair, inflammatory and cosmetic research peptides.
A naturally occurring copper complex researched in skin remodeling, tissue quality and repair contexts.
An investigational GIP, GLP-1 and glucagon receptor agonist studied for obesity and metabolic outcomes.
A naturally produced antioxidant researched in oxidative stress, redox balance and pigmentation contexts.
A mitochondrial-derived peptide studied in metabolic signaling, cellular stress and exercise models.
An approved dual GIP and GLP-1 receptor agonist studied across type 2 diabetes, obesity and cardiometabolic outcomes.
An approved GLP-1 receptor agonist with formulation- and indication-specific evidence for diabetes, weight management and cardiovascular outcomes.
An investigational long-acting amylin analogue studied alone and with semaglutide for weight management.
An investigational fixed combination of cagrilintide and semaglutide studied in metabolic and weight-management trials.
A GHRF analogue approved for reduction of excess abdominal fat in adults with HIV and lipodystrophy, with additional research contexts.
A modified growth-hormone fragment studied in metabolic and obesity research, with limited supportive clinical efficacy data.
A small-molecule NNMT inhibitor studied primarily in preclinical metabolic and adipose-tissue models.
An investigational GLP-1 and glucagon receptor dual agonist in clinical development for obesity and metabolic liver disease.
A GLP-1 and glucagon receptor dual agonist studied in obesity and type 2 diabetes, with development and regulatory status varying by region.
An investigational GLP-1 and glucagon receptor dual agonist studied for obesity and metabolic liver disease.
An approved daily GLP-1 receptor agonist studied for type 2 diabetes, weight management and cardiovascular outcomes.
A copper-binding tripeptide studied in ex vivo human hair follicles and cultured dermal papilla cells.
A non-standardized commercial blend name that may combine copper, repair or antioxidant components depending on the vendor.
A three-amino-acid melanocortin fragment studied in intestinal transport and inflammatory models.
A synthetic N-acetylated fragment associated with thymosin beta-4 research and anti-doping analysis.
A thymic peptide with human clinical research across infectious, immune and oncology contexts; regulatory status varies by country.
An endogenous antimicrobial peptide studied in innate immunity, inflammatory signaling and wound biology.
A mitochondria-targeted peptide with clinical research across mitochondrial disorders and a U.S. accelerated approval for Barth syndrome.
An endogenous coenzyme central to redox chemistry and cellular energy, distinct from its oral precursor compounds.
A synthetic tetrapeptide studied mainly in cellular and preclinical aging models, with limited independently replicated human evidence.
A mitochondrial-derived peptide studied in cellular stress, metabolism and age-associated disease models.
A melanocortin receptor agonist approved in the U.S. for acquired, generalized HSDD in premenopausal women under defined label conditions.
An endogenous neuropeptide central to GnRH signaling, studied in reproductive endocrinology and psychosexual research.
A peptide hormone with established obstetric uses and research spanning lactation, social processing and sexual function.
A selective ghrelin-receptor agonist studied as a growth hormone secretagogue, with limited modern human clinical evidence.
A long-acting growth hormone-releasing hormone analogue studied in healthy adults for GH and IGF-1 pharmacodynamics.
A GHRH(1-29) analogue formerly approved for pediatric diagnostic and treatment contexts and later discontinued commercially.
A synthetic peptide developed from an ACTH fragment and studied mainly in Russian-language neurologic and cognitive research.
A synthetic tuftsin-derived peptide studied mainly in Russian-language anxiety, immune and neurobehavioral research.
SIGNATURE TOOL · 01
Add peptides, select protocol variations, and automatically estimate vials, BAC water, syringes and supplies.
SIGNATURE TOOL · 02
UTILITY INDEX
LATEST RESEARCH REVIEW
What human trials show.
THE SIGNAL